Guardian Research Network, Inc.® (GRN) and ThinkGenetic, Inc. announce a strategic collaboration to accelerate the diagnosis and support the development of treatment options for patients with rare and genetic diseases.
ThinkGenetic
Finding Patients At Risk for Rare Disease
Together let’s systematically accelerate detecting at-risk individuals.
ThinkGenetic does not provide medical advice, diagnosis or treatment. Click here for more information.